Home › Esophageal Adenocarcinoma › Pennsylvania › Philadelphia
Pag-aaral pangklinika para sa Esophageal Adenocarcinoma sa Philadelphia, PA
Isang pag-aaral para sa Esophageal Adenocarcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Nagre-recruitPhase 2/3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi ang layo
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Nagre-recruitPhase 3
- Thomas Jefferson University Hospital, Philadelphia
- Einstein Medical Center Philadelphia, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi ang layo
- at 2 pa
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Nagre-recruitPhase 2/3
- Alliance Cancer Specialists, PC, Wynnewood · 7 mi ang layo
- Alliance Cancer Specialists, PC, Media · 12 mi ang layo
- Alliance Cancer Specialists, PC, Horsham · 16 mi ang layo
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Nagre-recruit
- University of Pennsylania, Perelman School of Medicine, Philadelphia
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Nagre-recruitPhase 3
- Research Site, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Nagre-recruitPhase 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Nagre-recruitPhase 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Pag-aaral para sa Esophageal Adenocarcinoma sa ibang lungsod
- New York City, NY18 pag-aaral
- Boston, MA13 pag-aaral
- Houston, TX12 pag-aaral
- Nashville, TN11 pag-aaral
- Arlington, VA11 pag-aaral
- Durham, NC10 pag-aaral
- Jacksonville, FL9 pag-aaral
- St. Louis, MO9 pag-aaral
- Rochester, MN9 pag-aaral
- Baldwin Park, CA9 pag-aaral
- Queens, NY9 pag-aaral
- Los Angeles, CA9 pag-aaral
Iba pang pag-aaral sa Philadelphia
- Kanser (lahat ng uri)59 pag-aaral
- Kanser sa Suso56 pag-aaral
- Non-Small Cell Lung Cancer51 pag-aaral
- Metastatic Cancer46 pag-aaral
- Kanser sa Prostate44 pag-aaral
- Colorectal Cancer44 pag-aaral
- Kanser sa Ovary44 pag-aaral
- Kanser sa Baga36 pag-aaral
- Acute Myeloid Leukemia34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Kanser ng Endometrium28 pag-aaral
- Depression26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.